Karyopharm Therapeutics (KPTI) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free KPTI Stock Alerts $1.09 -0.04 (-3.54%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Karyopharm Therapeutics Short Interest DataCurrent Short Volume22,950,000 sharesPrevious Short Volume23,130,000 sharesChange Vs. Previous Month-0.78%Dollar Volume Sold Short$34.65 millionShort Interest Ratio / Days to Cover13.3Last Record DateMarch 31, 2024Outstanding Shares115,067,000 sharesPercentage of Shares Shorted19.94%Today's Trading Volume1,591,056 sharesAverage Trading Volume1,114,714 sharesToday's Volume Vs. Average143% Short Selling Karyopharm Therapeutics ? Sign up to receive the latest short interest report for Karyopharm Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKPTI Short Interest Over TimeKPTI Days to Cover Over TimeKPTI Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Karyopharm Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202422,950,000 shares $34.65 million -0.8%N/A13.3 $1.51 3/15/202423,130,000 shares $34.93 million -1.3%N/A13.1 $1.51 2/29/202423,440,000 shares $27.19 million +0.0%N/A12.5 $1.16 2/15/202423,430,000 shares $30.46 million +24.0%N/A13.3 $1.30 1/31/202418,900,000 shares $14.18 million +1.2%N/A12 $0.75 1/15/202418,680,000 shares $13.90 million +4.1%N/A15.8 $0.74 Get the Latest News and Ratings for KPTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202317,950,000 shares $15.53 million +1.2%N/A15.6 $0.87 12/15/202317,740,000 shares $13.75 million -4.3%N/A14.4 $0.77 11/30/202318,530,000 shares $14.27 million -1.9%N/A16.4 $0.77 11/15/202318,890,000 shares $13.71 million +5.5%N/A16.3 $0.73 10/31/202317,910,000 shares $15.58 million +1.8%N/A13.9 $0.87 10/15/202317,590,000 shares $20.93 million +5.7%N/A12.1 $1.19 9/30/202316,640,000 shares $22.30 million +10.6%N/A7.7 $1.34 9/15/202315,040,000 shares $18.20 million +2.2%N/A6.5 $1.21 8/31/202314,710,000 shares $18.83 million +1.4%N/A5.2 $1.28 8/15/202314,510,000 shares $25.54 million -3.3%N/A4.9 $1.76 7/31/202315,000,000 shares $27 million +8.3%N/A4.8 $1.80 7/15/202313,850,000 shares $21.61 million +10.4%N/A4.2 $1.56 6/30/202312,550,000 shares $22.46 million -24.0%N/A4.3 $1.79 6/15/202316,520,000 shares $34.20 million +0.3%N/A5.7 $2.07 5/31/202316,470,000 shares $37.22 million -3.8%N/A6.3 $2.26 5/15/202317,120,000 shares $42.46 million -4.7%N/A6.6 $2.48 4/30/202317,960,000 shares $64.30 million +1.1%N/A6.9 $3.58 4/15/202317,760,000 shares $76.72 million -7.0%N/A7.6 $4.32 3/31/202319,090,000 shares $74.26 million +14.1%N/A7.3 $3.89 3/15/202316,730,000 shares $58.22 million -8.7%N/A6.1 $3.48 2/28/202318,330,000 shares $55.36 million -14.1%N/A6.6 $3.02 2/15/202321,330,000 shares $78.07 million -7.8%N/A7.9 $3.66 1/31/202323,140,000 shares $76.36 million +6.8%N/A8.8 $3.30 1/15/202321,670,000 shares $71.51 million +3.6%N/A8.1 $3.30 12/30/202220,910,000 shares $71.09 million +27.3%N/A9 $3.40 12/15/202216,430,000 shares $53.07 million +20.6%23.0%7.8 $3.23 11/30/202213,620,000 shares $72.05 million -0.2%19.1%7.7 $5.29 11/15/202213,640,000 shares $76.79 million +0.9%19.1%7.6 $5.63 10/31/202213,520,000 shares $64.36 million -1.2%18.6%7.5 $4.76 10/15/202213,690,000 shares $65.58 million +1.9%19.1%7.5 $4.79 9/30/202213,440,000 shares $73.38 million -5.8%18.8%7.3 $5.46 9/15/202214,260,000 shares $73.72 million -5.5%19.9%7.5 $5.17 8/31/202215,090,000 shares $76.36 million -11.4%21.1%7.1 $5.06 8/15/202217,030,000 shares $93.15 million -5.2%23.8%7.8 $5.47Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. KPTI Short Interest - Frequently Asked Questions What is Karyopharm Therapeutics' current short interest? Short interest is the volume of Karyopharm Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 22,950,000 shares of KPTI short. Learn More on Karyopharm Therapeutics' current short interest. What is a good short interest ratio for Karyopharm Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KPTI shares currently have a short interest ratio of 13.0. Learn More on Karyopharm Therapeutics's short interest ratio. Which institutional investors are shorting Karyopharm Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Karyopharm Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Karyopharm Therapeutics' short interest increasing or decreasing? Karyopharm Therapeutics saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 22,950,000 shares, a decrease of 0.8% from the previous total of 23,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Karyopharm Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Karyopharm Therapeutics: Eliem Therapeutics, Inc. (0.07%), CytomX Therapeutics, Inc. (4.90%), Vistagen Therapeutics, Inc. (5.27%), FibroGen, Inc. (5.65%), Nuvectis Pharma, Inc. (12.12%), Repare Therapeutics Inc. (2.39%), OptiNose, Inc. (2.76%), Sagimet Biosciences Inc. (19.41%), Citius Pharmaceuticals, Inc. (7.81%), Coya Therapeutics, Inc. (1.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Karyopharm Therapeutics stock? Short selling KPTI is an investing strategy that aims to generate trading profit from Karyopharm Therapeutics as its price is falling. KPTI shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Karyopharm Therapeutics? A short squeeze for Karyopharm Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KPTI, which in turn drives the price of the stock up even further. How often is Karyopharm Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KPTI, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ELYM Short Interest CTMX Short Interest VTGN Short Interest FGEN Short Interest NVCT Short Interest RPTX Short Interest OPTN Short Interest SGMT Short Interest CTXR Short Interest COYA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KPTI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing